KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Repurchased (2016 - 2024)

Jazz Pharmaceuticals (JAZZ) has 10 years of Shares Repurchased data on record, last reported at $150.0 million in Q3 2024.

  • For Q3 2024, Shares Repurchased rose 101.69% year-over-year to $150.0 million; the TTM value through Dec 2025 reached $150.0 million, down 53.73%, while the annual FY2025 figure was $125.0 million, 59.86% down from the prior year.
  • Shares Repurchased reached $150.0 million in Q3 2024 per JAZZ's latest filing, up from $99.8 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $150.0 million in Q3 2024 and bottomed at $7.5 million in Q2 2020.
  • Average Shares Repurchased over 3 years is $94.1 million, with a median of $99.8 million recorded in 2023.
  • Peak YoY movement for Shares Repurchased: tumbled 87.5% in 2020, then skyrocketed 101.69% in 2024.
  • A 3-year view of Shares Repurchased shows it stood at $7.5 million in 2020, then surged by 1233.44% to $99.8 million in 2023, then soared by 50.31% to $150.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $150.0 million in Q3 2024, $99.8 million in Q4 2023, and $74.4 million in Q3 2023.